0.01
—
Close of 30 Oct 2026, in USD
About JRsis Health Care
From its filings with the US Securities and Exchange Commission
JRsis Health Care is based in Wuguishan, Zhongshan City, China and is incorporated in Florida. Its shares trade on OTC under the ticker JRSS. The SEC classifies its business as hospitals. In the fiscal year to 31 December 2023, it reported revenue of $3.5m and a net loss of $80,912. At that date it held total assets of $2.1m and shareholders' equity of −$137,406.
“JRSIS–BVI” identifies JRSIS Health Care Limited, a wholly-owned subsidiary of JRSIS that is organized in the British Virgin Islands (“BVI”).
“Runteng” identifies Runteng Medical Group Company Limited, a wholly-owned subsidiary of JRSIS-BVI that is organized in Hong Kong.
“Laidian” identifies Laidian Technology (Zhongshan) Co., Ltd., a wholly-owned subsidiary of Runteng that is organized in the PRC.
“Yongzhou Jumi” identifies Yongzhou Jumi Intelligent Technology Co., Ltd., an independent entity consolidated with JRSIS for financial reporting purposes.
“Company” identifies JRSIS, JRSIS-BVI, Runteng, Laidian and Yongzhou Jumi as entities consolidated for financial reporting purposes.
Guangzhou Jumi which owns all of the registered equity in Yongzhou Jumi, has entered into an Equity Interest Pledge Agreement with Laidian.
Jumi has fully performed its obligations under the Exclusive Business Consulting Agreement.
Yongzhou Jumi may not merge with or acquire any third parties, or make investment in any third parties.
Guangzhou Jumi grants to Laidian the authority to exercise all of the powers given to Guangzhou Jumi as a shareholder of Yongzhou Jumi.
Quoted from its 10-K, filed 26 Apr 2024. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 6 Mar 2014
- Employees
- 811
- Website
- jhcc.cn ↗
- Head office
- 3/F BUILDING A, DERUN YUAN, WUGUISHAN, ZHONGSHAN CITY, F4, 528458
- Incorporated in
- FL
- Classification
- Services-Hospitals
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Linhai ZhuChairman of the Board, President, Chief Executive Officer, Chief Financial Officer, since 2023
- Mr. Zhuowei ZhongCompany Secretary, Director, since 2022
- Ms. Mary XingIR Contact Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in Harbin, Heilongjiang with 811 full-time employees.
- Offers a diverse range of medical services including Western and Chinese practices.
- Equipped with four ambulances available 24 hours a day.
Weaknesses
- Sector and industry information are listed as N/A.
- No specific financial data or performance metrics provided.
- Products listed include various medical specialties without additional details.
Opportunities
- Potential to expand services in both Western and Chinese medical practices.
- Growth opportunities in the healthcare sector with a 2014 IPO.
- Possibility to leverage the 24-hour ambulance service for market differentiation.
Threats
- Lack of sector and industry classification may hinder market positioning.
- Unverified product listings could lead to credibility issues.
- No mention of competitors or market challenges in the provided information.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.